Medical News: Antibodies to Adalimumab Hinder Tx Response - in Clinical Context, Rheumatoid Arthritis from MedPage Today

Links shared publicly online about this topic.

  • 370
    total visits

Medical News: Antibodies to Adalimumab Hinder Tx Response - in Clinical Context, Rheumatoid Arthritis from MedPage Today

medpagetoday.com —

The development of antibodies against the biologic agent adalimumab (Humira) during treatment was associated with a lack of efficacy and low rates of remission among patients with rheumatoid arthritis

View full resource at medpagetoday.com

Tags: Crohn's Disease Medication, Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Healthy Living, Humira, News, Medical

  • Share

Most Recently Shared on April 12, 2011 at 2:39 pm By:

MedicalNews Medical News

Antibodies to Adalimumab Hinder Tx Response (CME/CE) http://bit.ly/eplSf3

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

Thomas Loarie, Jr Thomas Loarie, Jr

Advertisement